 Longeveron Inc. NASDAQ:LGVN Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations Chris Min - Interim Chief Executive Officer Chief Medical Officer James Clavijo - Chief Financial Officer Joshua Hare - Co-Founder, Chief Science Officer Chairman Conference Call Participants Michael Okunewitch - Maxim Group Operator Ladies and gentlemen, thank you for standing by. Welcome to the Longeveron 2022 Second Quarter Earnings Call. 